No spam - just the good stuff
Subscribe to our newsletter
First Name
(Required)
Email Address
(Required)
Hidden
Contact Source
News
Investor Portal
Lifestyle
Videos
Search for:
Search
More
Contact
Features
News
Home
Biotech
Investment
Diagnostics
Agetech
Supplements
Innovation
AI/Digital
Economy
‘I want medical tourism to be open to everyone, forever’
BioViva's CEO Liz Parrish on de-risking regulatory systems and creating evidence-based medicine from medical tourism.
Features
Videos
Researchers land $3.2m to study impact of microbiome disruption on Alzheimer’s
Innovation
Investment
Investment
‘It’s always too early to say something’s impossible’
Videos
Physicians want AI tech to help dementia patients live longer
Agetech
AI/Digital
Insilico and University of Cambridge present new approach for discovering targets for Alzheimer’s
AI/Digital
Crucible Therapeutics spins out with £5m for neurodegenerative disease gene therapies
Investment
Investment
SenoClock Gold: Bringing the antiaging paradigm to work
AI/Digital
Economy
Can AI help you live longer?
AI/Digital
Features
Vivante gobbles up $31m for digestive health tech
AI/Digital
Investment
Investment
Will psychedelics produce the next longevity drug?
Innovation
Genflow makes progress towards clinical trial of NASH gene therapy
Biotech
‘We are information machines – and it’s time to renew the code.’
Investment
Investment
Videos
VitaDAO and GlycanAge explore longevity and DeSci in Abu Dhabi event
Economy
Most Popular
Longevity investment bulletin: NewLimit, ORA, Insilico Medicine and more
Investment
Investment
Stay cool: the longevity tech that “shows insane promise”
Features
Videos
Does SIRT6 hold the key to human longevity?
Biotech
Tally up! Consumer longevity company lands $10m
Diagnostics
Investment
Investment
Innovation
Researchers land $3.2m to study impact of microbiome disruption on Alzheimer’s
Researchers at the University of Alabama to investigate the effects of microbiome disruption on Alzheimer’s disease progression.
Will psychedelics produce the next longevity drug?
Dr Halland Chen on longevity medicine, mindset and the potential of psychedelics to improve human longevity.
New study reveals how neurons die in Alzheimer’s disease
Breakthrough research illustrates how neurons initiate a programmed form of cell death – and how neuron death can be prevented.
Leveraging the past to illuminate longevity for the future
Rooted in Amish genetic knowledge, Zoe Biosciences’ novel platform could become the gold standard for delayed human aging.
Economy
SenoClock Gold: Bringing the antiaging paradigm to work
VitaDAO and GlycanAge explore longevity and DeSci in Abu Dhabi event
Longevity.Technology announces entry into Asia Pacific markets
Ending Aging Forum 2023
Longevity on the rise
Treat the mind, treat the body: Addressing a fundamental gap in acute disease management
Supplements
NMN Bio and Aster Pharmacy unite to bring antiaging supplements to UAE market
Partnership aims to set a new standard for health and wellness in the United Arab Emirates.
Supplements
First-ever clinical trial of ketone supplementation to treat and prevent frailty
Supplements
Thorne to be acquired by L Catterton for $680 million in cash
Supplements
Researchers develop compound that prevents free radical production in mitochondria
Supplements
Avea secures $5 million in seed funding
Supplements
Longevity: This time it’s personal
Supplements
Taurine deficiency: New research identifies possible driver for aging
Supplements
A strong patent portfolio delivers a competitive edge in the longevity space
Supplements
Combilytics: Taking a combined approach to senescence
Supplements
Editor's pick
Leveraging the past to illuminate longevity for the future
Features
Innovation
Investment
Investment
‘It’s always too early to say something’s impossible’
Videos
‘Longevity is the biggest revolution in the history of Homo sapiens – don’t die!’
Features
Videos
Calling all longevity clinicians: your voice matters!
Diagnostics
Investment
Researchers land $3.2m to study impact of microbiome disruption on Alzheimer’s
Researchers at the University of Alabama to investigate the effects of microbiome disruption on Alzheimer’s disease progression.
Crucible Therapeutics spins out with £5m for neurodegenerative disease gene therapies
Gene therapy company emerges with £5 million ($6.1 million) in funding to target neurodegenerative disease.
Vivante gobbles up $31m for digestive health tech
Digital digestive health company concludes a $31 million Series B funding round to advance its gut health platform GIThrive.
‘We are information machines – and it’s time to renew the code.’
Methuselah Foundation's CEO David Gobel on clinging to the longevity biotech mast while waiting for the rising tide.
Diagnostics
FDA clears AI tool for early Alzheimer’s detection from MRI scans
New panel set to aid detection of inflammation and biological stress biomarkers
Sonera exits stealth with $11m for neural sensing chip technology
New blood test detects key indicator of Parkinson’s disease
Viome lands $86.5m and US retail deal for gut health test
Dialing up human longevity
Watch now
‘I want medical tourism to be open to everyone, forever’
BioViva's CEO Liz Parrish on de-risking regulatory systems and creating evidence-based medicine from medical tourism.
Videos
‘We are information machines – and it’s time to renew the code.’
Videos
‘It’s always too early to say something’s impossible’
Videos
‘We’re at the longevity inflection point – and the explosion is coming.’
Videos
Longevity to a sirtuin extent
Videos
‘Longevity is the biggest revolution in the history of Homo sapiens – don’t die!’
Videos
Longevity: This time it’s personal
Videos
SIRT6: The protein that talks the talk and walks the walk
Videos
Navigate the emerging field of longevity
Videos
Agetech
Physicians want AI tech to help dementia patients live longer
Two-thirds of UK GPs want to prescribe tech for their dementia patients to help them remain independent and live longer.
Connected technologies are changing the future of aging at home
Huong Le Dieu, Lead Product Manager of BLabs at Baracoda Daily Healthtech, on why it's time to take aging in place to the next level.
AI innovations to transform living with dementia awarded £1.9 million
Longitude Prize on Dementia champions personalized tech that to helps people living with dementia enjoy independent and fulfilled lives.
Clearday and Viveon Health SPAC announce merger agreement to accelerate innovative longevity tech
Definitive merger agreement set to accelerate robotic companion care/AI longevity tech platform to market.
Biotech
Genflow makes progress towards clinical trial of NASH gene therapy
The quest for rejuvenation without reprogramming
Nine Square Therapeutics lands $4.5m to advance development of novel Parkin activators
Rejuveron lands $75m to advance healthy aging portfolio; expands focus in Middle East
Alnylam drug shown to reduce blood pressure in Phase 2 trial
Telomere-boosting mRNA therapeutic turns back the aging clock
AI/Digital
Physicians want AI tech to help dementia patients live longer
Insilico and University of Cambridge present new approach for discovering targets for Alzheimer’s
SenoClock Gold: Bringing the antiaging paradigm to work
Can AI help you live longer?